We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

84 hedge funds and large institutions have $11M invested in Ampio Pharmaceuticals Inc. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,814% more call options, than puts

Call options by funds: $204K | Put options by funds: $7K

52% more capital invested

Capital invested by funds: $7.24M → $11M (+$3.76M)

13% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 15

6% less funds holding

Funds holding: 89 → 84 (-5)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

Holders
84
Holders Change
-5
Holders Change %
-5.62%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
17
Reduced
15
Closed
10
Calls
$204K
Puts
$7K
Net Calls
+$197K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$332K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$316K
3
WS
Wedbush Securities
California
+$187K
4
Northern Trust
Northern Trust
Illinois
+$76.6K
5
RJA
Raymond James & Associates
Florida
+$62.9K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$109K
2
GCP
GSA Capital Partners
United Kingdom
-$60.6K
3
Citadel Advisors
Citadel Advisors
Florida
-$57.9K
4
UBS Group
UBS Group
Switzerland
-$44K
5
Group One Trading
Group One Trading
Illinois
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
BJL
26
Brighton Jones LLC
Washington
$57K – – –
GIA
27
GHP Investment Advisors
Colorado
$56K – – –
Two Sigma Advisers
28
Two Sigma Advisers
New York
$54K +$171 +1 +0.3%
Wells Fargo
29
Wells Fargo
California
$50K -$171 -1 -0.3%
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$49K – – –
AG
31
Advisor Group
Arizona
$36K – – –
AIG
32
American International Group
New York
$35K -$1.2K -7 -3%
SGCA
33
Steel Grove Capital Advisors
Tennessee
$31K – – –
RJFSA
34
Raymond James Financial Services Advisors
Florida
$28K – – –
Citigroup
35
Citigroup
New York
$28K +$6.85K +40 +32%
Goldman Sachs
36
Goldman Sachs
New York
$27K -$15.8K -92 -36%
TCM
37
Traynor Capital Management
Pennsylvania
$23K +$4.97K +29 +26%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$22K – – –
Group One Trading
39
Group One Trading
Illinois
$19K -$37K -216 -65%
CCB
40
Cutter & Co Brokerage
Missouri
$19K -$2.23K -13 -10%
UCFA
41
United Capital Financial Advisors
Texas
$19K – – –
CPIG
42
Chicago Partners Investment Group
Illinois
$18K +$6.17K +36 +47%
Barclays
43
Barclays
United Kingdom
$16K +$16.3K +95 New
Citadel Advisors
44
Citadel Advisors
Florida
$15K -$57.9K -338 -79%
Creative Planning
45
Creative Planning
Kansas
$15K – – –
State Board of Administration of Florida Retirement System
46
State Board of Administration of Florida Retirement System
Florida
$15K – – –
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$14.6K +$13.7K +80 +1,333%
Morgan Stanley
48
Morgan Stanley
New York
$14K -$109K -637 -89%
JWA
49
JFS Wealth Advisors
Pennsylvania
$14K – – –
JP Morgan Chase
50
JP Morgan Chase
New York
$13K -$514 -3 -4%
1
2
3 4

AMPE Hedge Fund Activity: Q1 2019 in Review

84 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2019, worth a combined $11M — up 52% from $7.24M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AMPE and 5 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 17 added.

The largest buyer was BlackRock, adding an estimated $332K. The largest seller was Morgan Stanley, cutting an estimated $109K.

  • 84 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2019, down from 89 in Q4 2018.
  • Funds reported $11M of Ampio Pharmaceuticals Inc. stock for Q1 2019, up 52% quarter-over-quarter.
  • 5 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2019 and 10 closed out, a net change of -5 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2019 was BlackRock, an estimated $332K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2019 was Morgan Stanley, an estimated $109K sold.

Based on aggregated 13F filings for Q1 2019.